A company insider recently sold 6,547 shares of G1 Therapeutics Inc [GTHX]. Should You Sale?
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. G1 Therapeutics Inc shares valued at $19,752 were sold by Umstead John W. V on Mar 18 ’24. At $3.02 per share, Umstead John W. V sold 6,547 shares. The insider’s […]
G1 Therapeutics Inc (GTHX) may enjoy gains as insiders got busy in the recent days
In a filing, G1 Therapeutics Inc revealed its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported $19752.0 on Mar 18 ’24. In the deal valued at $3.02 per share,6,547 shares were sold. As a result of this transaction, Umstead John W. V now holds 123,896 shares worth roughly $0.56 million. Then, […]
GTHX stock rated a Neutral by JP Morgan
G1 Therapeutics Inc’s recently made public that its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported $19752.0 on Mar 18 ’24. In the deal valued at $3.02 per share,6,547 shares were sold. As a result of this transaction, Umstead John W. V now holds 123,896 shares worth roughly $0.59 million. Then, […]
G1 Therapeutics Inc [GTHX] short interest falls, dropping by 2.69 million million shares
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. G1 Therapeutics Inc shares valued at $19,752 were sold by Umstead John W. V on Mar 18 ’24. At $3.02 per share, Umstead John W. V sold 6,547 shares. The insider’s […]
G1 Therapeutics Inc [GTHX] Umstead John W. V sells 6,547 Shares for $19752.0
G1 Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported $19752.0 on Mar 18 ’24. In the deal valued at $3.02 per share,6,547 shares were sold. As a result of this transaction, Umstead John W. V now holds 123,896 shares worth roughly $0.56 million. Then, […]
G1 Therapeutics Inc [GTHX] Records 50-Day SMA of $3.52
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. G1 Therapeutics Inc shares valued at $19,752 were sold by Umstead John W. V on Mar 18 ’24. At $3.02 per share, Umstead John W. V sold 6,547 shares. The insider’s holdings dropped to […]
JP Morgan’s latest rating for GTHX stock
In a filing, G1 Therapeutics Inc revealed its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported $19752.0 on Mar 18 ’24. In the deal valued at $3.02 per share,6,547 shares were sold. As a result of this transaction, Umstead John W. V now holds 123,896 shares worth roughly $0.5 million. Then, […]
